PMID- 30178769
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220412
IS  - 0972-9941 (Print)
IS  - 1998-3921 (Electronic)
IS  - 1998-3921 (Linking)
VI  - 16
IP  - 1
DP  - 2020 Jan-Mar
TI  - Video-assisted mediastinoscopy is safe in patients taking antiplatelet or 
      anticoagulant therapy.
PG  - 30-34
LID - 10.4103/jmas.JMAS_173_18 [doi]
AB  - BACKGROUND: The aim of this study was to report our experience with 
      video-assisted mediastinoscopy (VAM) in patients taking antiplatelet (AP) or 
      anticoagulant therapies focusing on perioperative complications (especially 
      haemorrhagic). PATIENTS AND METHODS: We have done a retrospective study from a 
      prospectively maintained database with diagnostic VAM (01/2008-06/2012). We 
      included 54 patients with AP (41 patients - Group A) and anticoagulant (13 
      patients - Group B) therapies. The control group was formed by 263 patients 
      (Group C). Data regarding the clinical records of the patients, operative time, 
      per- and post-operative complications, total numbers of biopsies and the results 
      of the pathologic examination were collected. We compared the groups A+B versus 
      C, and then A versus C. Statistical differences were calculated by Chi-square 
      test. RESULTS: In Group A, we had two minor complications: cardiac arrhythmia and 
      peroperative minor haemorrhage. The mean operative time was 29 min and the mean 
      post-operative stay was 1.08 days. In Group B, we had one minor complication: 
      Peroperative minor haemorrhage. The mean operative time was 35 min and the mean 
      post-operative stay was 1.07 days. In Group C, the mean operative time was 28 
      min. One death occurred (mortality rate of 0.38%) because of cardiac arrest at 
      the induction of anaesthesia. One major complication occurred (severe respiratory 
      insufficiency needing re-intubation) and eight minor complications. Morbidity 
      rate was 2.28%. Mean post-operative stay was 1.14 days. No statistical difference 
      was noted between groups. CONCLUSION: VAM can be safely performed in patients 
      receiving AP or anticoagulant treatments. There is no increase in peroperative 
      bleeding or post-operative compressive cervico-mediastinal haematoma.
FAU - Cohen, Charlotte
AU  - Cohen C
AD  - Department of Thoracic Surgery, Pasteur Hospital, Nice, France.
FAU - Pop, Daniel
AU  - Pop D
AD  - Department of Thoracic Surgery, Pasteur Hospital, Nice, France.
FAU - Aze, Olivier
AU  - Aze O
AD  - Department of Thoracic Surgery, Pasteur Hospital, Nice, France.
FAU - Venissac, Nicolas
AU  - Venissac N
AD  - Department of Thoracic Surgery, Pasteur Hospital, Nice, France.
FAU - Mouroux, Jerome
AU  - Mouroux J
AD  - Department of Thoracic Surgery, Pasteur Hospital, Nice, France.
LA  - eng
PT  - Journal Article
PL  - India
TA  - J Minim Access Surg
JT  - Journal of minimal access surgery
JID - 101228183
PMC - PMC6945347
OTO - NOTNLM
OT  - Lung neoplasm
OT  - minimally invasive
OT  - surgery
COIS- None
EDAT- 2018/09/05 06:00
MHDA- 2018/09/05 06:01
PMCR- 2020/01/01
CRDT- 2018/09/05 06:00
PHST- 2018/09/05 06:00 [pubmed]
PHST- 2018/09/05 06:01 [medline]
PHST- 2018/09/05 06:00 [entrez]
PHST- 2020/01/01 00:00 [pmc-release]
AID - 240461 [pii]
AID - JMAS-16-30 [pii]
AID - 10.4103/jmas.JMAS_173_18 [doi]
PST - ppublish
SO  - J Minim Access Surg. 2020 Jan-Mar;16(1):30-34. doi: 10.4103/jmas.JMAS_173_18.